Author: Amrita Banerjee; Dipannita Santra; Smarajit Maiti
Title: Energetics based epitope screening in SARS CoV-2 (COVID 19) spike glycoprotein by Immuno-informatic analysis aiming to a suitable vaccine development Document date: 2020_4_5
ID: iy4knx7j_26
Snippet: The spike glycoprotein structures of seven coronavirus including the recent outbreaking strain SARS CoV-2 (Covid 19) presented in table 1. The Ramachandran plot data and structural alignment data suggests that SARS CoV and SARS CoV-2 (Covid-2) has higher degree of alignment (Table 1 ). The protein sequences were ranged from 1173-1356 amino acids. An effort was made for epitope based peptide vaccine development by searching MHC-I and II classes co.....
Document: The spike glycoprotein structures of seven coronavirus including the recent outbreaking strain SARS CoV-2 (Covid 19) presented in table 1. The Ramachandran plot data and structural alignment data suggests that SARS CoV and SARS CoV-2 (Covid-2) has higher degree of alignment (Table 1 ). The protein sequences were ranged from 1173-1356 amino acids. An effort was made for epitope based peptide vaccine development by searching MHC-I and II classes compatible sites and the results yet to come [33] . In the current study, energetic and Inhibition Concentration50 based selection of SARS CoV-2 spike epitope and its possible glycosylation effect/structural-hindrance have been evaluated. This may help in urgent vaccination strategies in the current disastrous situation. Higher degree of similarity between SARS CoV and SARS CoV-2 might indicate and help in the therapeutic and vaccination strategies with reference to the current global situation.
Search related documents:
Co phrase search for related documents- amino acid and current study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- amino acid and global situation: 1
- amino acid and glycoprotein structure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- amino acid and glycosylation effect: 1, 2, 3
- amino acid and high degree: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- amino acid and peptide vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- amino acid and peptide vaccine development: 1, 2, 3
- amino acid and protein sequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83
- amino acid and Ramachandran plot: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- amino acid and SARS SARS CoV similarity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- amino acid and spike epitope: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- amino acid and structural alignment: 1, 2, 3, 4, 5, 6
- amino acid and vaccination strategy: 1, 2, 3, 4, 5, 6
- compatible site and current study: 1
- compatible site and protein sequence: 1
Co phrase search for related documents, hyperlinks ordered by date